When assessing patients at a mental health clinic, how should their current level of overall functioning be judged?
A continuum from mentally healthy to mentally unhealthy
The rate of both their intellectual and emotional growth
The degree of conformity of the individual to society’s norms
The degree to which an individual appears logical and rational
The Correct Answer is A
Choice A reason: Assessing functioning on a continuum reflects the spectrum of mental health, from optimal to severe impairment. Tools like the Global Assessment of Functioning scale quantify symptom severity and social/occupational performance, integrating neurobiological factors like dopamine imbalances in schizophrenia or serotonin deficits in depression, providing a comprehensive evaluation of mental health status.
Choice B reason: Focusing on intellectual and emotional growth is irrelevant for current functioning. Mental disorders like anxiety or psychosis primarily disrupt mood and cognition, not developmental growth. Neurobiological changes, such as reduced prefrontal cortex activity in depression, affect daily performance, not growth rates, making this metric unsuitable for assessing overall mental health functioning.
Choice C reason: Judging by societal conformity ignores individual neurobiological differences. Mental illnesses, like bipolar disorder, involve altered brain activity (e.g., heightened amygdala response), not just nonconformity. This approach risks mislabeling cultural or personality variations as pathology, disregarding scientific evidence of brain-based dysfunction and hindering accurate assessment of mental health status.
Choice D reason: Assessing logical and rational appearance is insufficient, as disorders like schizophrenia can present with intact logic but severe delusions due to dopamine dysregulation. This overlooks emotional and social impairments, critical in mental health assessment, and fails to capture the full spectrum of neurobiological and functional deficits present in psychiatric conditions.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is A
Explanation
Choice A reason: Venlafaxine inhibits serotonin and norepinephrine reuptake, enhancing synaptic levels of these neurotransmitters in the prefrontal cortex and amygdala, improving mood and anxiety. This mechanism aligns with SNRIs, making it the correct choice for treating conditions like depression or anxiety with dual neurotransmitter modulation.
Choice B reason: Propranolol is a beta-blocker, reducing sympathetic activity by blocking norepinephrine at beta receptors, not reuptake. It treats physical anxiety symptoms, not mood via serotonin-norepinephrine pathways. This makes it incorrect for an SNRI, as it lacks reuptake inhibition properties.
Choice C reason: Amitriptyline, a tricyclic antidepressant, inhibits serotonin and norepinephrine reuptake but also affects other receptors, causing significant side effects. It is not classified as an SNRI due to its broader mechanism, making it an incorrect choice compared to venlafaxine’s specific SNRI action.
Choice D reason: Fluoxetine is an SSRI, selectively inhibiting serotonin reuptake, not norepinephrine. It enhances serotonin in mood-regulating areas like the hippocampus but lacks norepinephrine modulation, making it incorrect for an SNRI, which requires dual reuptake inhibition for broader neurotransmitter effects.
Correct Answer is A
Explanation
Choice A reason: Muscarinic receptor blockers inhibit parasympathetic activity, reducing salivary gland secretion via acetylcholine pathways. This causes dry mouth, as muscarinic receptors in salivary glands are blocked, decreasing saliva production. This anticholinergic effect is common in drugs like benztropine, requiring assessment to manage discomfort and prevent oral health issues.
Choice B reason: Orthostatic hypotension is linked to alpha-1 adrenergic blockade, not muscarinic receptors. Muscarinic blockers affect cholinergic pathways, not vascular tone regulated by norepinephrine. While autonomic effects occur, hypotension is not a primary consequence, making this side effect unrelated to muscarinic receptor antagonism.
Choice C reason: Pseudoparkinsonism results from dopamine receptor blockade, common in antipsychotics, not muscarinic blockers. Muscarinic receptors regulate parasympathetic functions like salivation, not motor control. Blocking muscarinic receptors may alleviate parkinsonism by balancing cholinergic-dopaminergic activity, making this an incorrect side effect for assessment.
Choice D reason: Gynecomastia is associated with hormonal imbalances or dopamine blockade, not muscarinic receptors. Muscarinic blockers affect cholinergic systems, not prolactin or estrogen pathways. This side effect is unrelated to muscarinic antagonism, which primarily causes anticholinergic effects like dry mouth, not endocrine changes.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today
Report Wrong Answer on the Current Question
Do you disagree with the answer? If yes, what is your expected answer? Explain.
Kindly be descriptive with the issue you are facing.